Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 25, 2021
Dec. 26, 2020
Current assets:    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $ 4,827 $ 5,865
Short-term investments 2,103 2,292
Trading assets 21,483 15,738
Accounts receivable, net of allowance for doubtful accounts 9,457 6,782
Inventories 10,776 8,427
Assets held for sale 6,942 5,400
Other current assets 2,130 2,745
Total current assets 57,718 47,249
Property, plant and equipment, net 63,245 56,584
Equity investments 6,298 5,152
Other long-term investments 840 2,192
Goodwill 26,963 26,971
Identified intangible assets, net 7,270 9,026
Other long-term assets 6,072 5,917
Total assets 168,406 153,091
Current liabilities:    
Short-term debt 4,591 2,504
Accounts payable 5,747 5,581
Accrued compensation and benefits 4,535 3,999
Other accrued liabilities 12,589 12,670
Total current liabilities 27,462 24,754
Debt 33,510 33,897
Contract Liabilities 185 1,367
Income taxes payable, non-current 4,305 4,578
Deferred income taxes 2,667 3,843
Other long-term liabilities 4,886 3,614
Commitments and Contingencies (Note 19)
Stockholders' equity:    
Preferred stock, $0.001 par value, 50 shares authorized; none issued 0 0
Common stock, $0.001 par value, 10,000 shares authorized; 4,070 shares issued and outstanding (4,062 issued and outstanding in 2020) and capital in excess of par value 28,006 25,556
Accumulated other comprehensive income (loss) (880) (751)
Retained earnings 68,265 56,233
Total stockholders' equity 95,391 81,038
Total liabilities and stockholders' equity $ 168,406 $ 153,091